Research Overview: PT-141 10mg Peptide Analysis
PT-141 is a synthetic melanocortin receptor agonist peptide that researchers investigate for its unique mechanism of action on central nervous system pathways. This 10mg formulation from Deus Medical provides laboratories with a standardised research compound for examining melanocortin-4 receptor interactions and associated neurological cascades. Research scientists studying peptide behaviour patterns frequently analyse PT-141’s molecular structure to understand its binding affinity and receptor selectivity profiles. The compound’s cyclic heptapeptide configuration makes it particularly valuable for investigating peptide stability and bioactivity retention in various experimental conditions. At Stroid UK Shop, researchers can access high-purity PT-141 alongside comprehensive analytical documentation supporting rigorous laboratory protocols.
Laboratory Applications and Research Protocols
Research facilities investigating melanocortin signalling pathways commonly examine PT-141 in controlled experimental settings. The compound’s selective agonism of MC3R and MC4R receptors provides researchers with valuable insights into central nervous system modulation mechanisms. Laboratories studying peptide pharmacokinetics analyse PT-141’s molecular interactions with various receptor subtypes, contributing to broader understanding of melanocortin system functionality. Research teams investigating neurological pathway modulation frequently compare PT-141’s activity profiles with other peptides to establish comprehensive activity mapping. Scientists examining peptide stability under varying pH and temperature conditions utilise PT-141 as a model compound for understanding cyclic peptide degradation patterns. Our endurance drugs peptides category provides researchers with complementary compounds for comparative analysis studies. Additionally, researchers exploring selective receptor modulation often cross-reference PT-141 studies with SARMs research to understand different molecular targeting approaches.
Technical Specifications and Analysis
| Parameter | Specification |
|---|---|
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| CAS Number | 189691-06-3 |
| Purity | ≥98% (HPLC verified) |
| Storage | -20°C, protect from light |
| Solubility | Water soluble |
| Appearance | White lyophilised powder |
Research Compliance and Laboratory Use
This PT-141 10mg peptide is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or clinical applications. Researchers must maintain proper laboratory protocols, including appropriate storage conditions, handling procedures, and waste disposal methods. All experimental work must comply with institutional research guidelines and regulatory frameworks governing peptide research.
